AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
From Iron Dome to Arrow missiles, unpaid bills accumulate in Israel’s defense sector
2
The 50 most promising Israeli startups - 2026
3
Indian Embassy cancels $42 million Tel Aviv office deal at last minute
4
Crypto unicorn MoonPay acquires Israeli security startup Sodot for $100 million
5
SAP taps Israeli executive to lead global AI push
More news

Biotech

20 stories about Biotech
מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Biotech Company Polypid Raises $15 Million

07.11.18|Lilach Baumer
Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body
default image

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18|Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
תל אביב קו רקיע Tel Aviv Skyline

Israel to Help Biotech Companies Go from Research to Manufacturing

04.11.18|Omri Milman
Companies looking to set up manufacturing facilities could receive grants covering 20%-30% of the costs
מייקל היידן מחקר ו פיתוח טבע

Former Teva Executives Raise $60 Million for Metabolic Disorders Venture

28.10.18|Lilach Baumer
The company’s pipeline of biologic and small molecule drug candidates was acquired from Teva
נאסדק

Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO

28.10.18|Lilach Baumer
The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share
קולפלנט דיו ביולוגי

Global Licensing and Commercialization Deal Catapults Collplant on Nasdaq

22.10.18|Lilach Baumer
The tissue regeneration company announced on Monday a deal with biotech company United Therapeutics and is currently up over 60% in pre-market trading
נאסד"ק וול סטריט

LogicBio Therapeutics Underperforms with $70 Million Nasdaq IPO

21.10.18|Lilach Baumer
Co-founded by Israel-born Adi Barzel, LogicBio develops genome-editing treatments for rare diseases
נאסד"ק וול סטריט

Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million

18.10.18|Lilach Baumer
The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms
נאסד"ק וול סטריט

Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO

30.09.18|Dror Reich
The Jerusalem-based company develops cellular and immune therapies. Its lead product is a universal bone marrow transplant solution
MeMed בדיקת דם מימין ערן אדן ו כפיר עובד

Automated Blood Tests Startup MeMed Raises $70 Million to Expand Offering

20.09.18|Omer Kabir
The company will use the funding to launch a new model of its blood testing device, and to expand the range of tests it offers
רנטגן שניים

Antiseptic Materials Startup Nobio Raises $3.6 Million

30.07.18|Asaf Shalev
The Israel-based startup plans to target the dental and medical device industry, offering technology to solve the infection and contamination when devices are placed in the body.
בדיקת דם 1

Cancer Screening Company Nucleix Raises 2.5 Million Euros

30.07.18|Lilach Baumer
Founded in 2008, Nucleix develops urine and blood-based non-invasive, molecular cancer screening tests
מעבדה רפואה 1 זירת הבריאות

Eli Lilly Signs Multi-Year Collaboration with Anima Biotech

23.07.18|Lilach Baumer
Israel-based Anima will receive an upfront payment of $30 million and $14 million for research, but could potentially get as much as $1.05 billion in milestones
default image

Evogene Signs Brazilian Partnership to Develop Pest-Resistant Cotton

18.07.18|Lilach Baumer
Israel-based Evogene will identify pest-resistant genes in cotton, and Brazilian crop research Instituto Mato-Grossense do Algodão will test their effectiveness
A colony of haploid human embryonic stem cells תאי גזע

NewStem, Which Screens Patients for Resistance to Chemotherapy, Raises $2 Million

16.07.18|Asaf Shalev
The Jerusalem-based startup is creating a proprietary database of mutated genes that cause resistance to different types of chemotherapeutic agents
PlantArcBio הצוות של מימין ד"ר דרור שליטין ד"ר נועם גרעמברג ד"ר ערבה שתיל כהן ד"ר אביבה כץ

Gene Discovery Startup Announces Breakthrough on Drought-Tolerant Crops

09.07.18|Asaf Shalev
Israel’s PlantArcBio has isolated the genes that help desert organisms survive. Now, the University of Wisconsin-Madison will test the genes’ impact on soybean yields
לן בלווטניק בעל השליטה בכת"ב

Three Portfolio Companies of Len Blavatnik's Clal Biotechnology Raise Cash in One Week

04.07.18|CTech
Clal Biotechnology Industries is an Israel-based life sciences investment company
נאסד"ק וול סטריט

Fourth Time’s the Charm for Entera Bio IPO

01.07.18|Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
default image

Ben Gurion University Launches $1 Million Investment Fund

23.05.18|Hagar Ravet
The fund will invest in technologies developed and conceived by BGU students and graduates in the fields of technology, biotech, and social engagement
Seevix

Startup Says It Is First to Copy Spider’s Silk Spinning Process

17.05.18|Asaf Shalev
Spider silk is not only strong, unbelievably elastic, and able to withstand extreme temperature, it is also biodegradable and biocompatible, a fact that’s especially important for medical applications
Previous ArticlesMore Articles